Synthetic Biology

Supported by Project 5-100 that aims at maximizing the competitive position of leading Russian universities in the global education market
A high relevance of this research field is confirmed by
world scientific community


Nobel Prizes 2012 in Physiology or Medicine Discovering the possibility to differentiated cell reprogramming into pluripotent ones
he recognition of genomic editing via CRISPR as a scientific breakthrough of the year 2015 by The Science journal
The Nobel Prize in Chemistry 2015 for mechanistic studies of DNA repair

Key achievements
R&D and engineering projects at the world scale
A set of enzymes has been developed for the improvement of degraded DNA quality in the analyses of low-quality biological specimens - "ancient DNA", archived medical probes, forensic probes, deeply processed food products and other.

A series of candidate substances has been obtained, based on natural compounds, for combined therapy of cancer, which brings together the damage of DNA and the inhibition of repair systems, - a new therapeutic approach, approved in 2015 in the USA and Europe.
Humanized monoclonal antibodies against tick-born encephalitis virus have been developed to replace high-cost, not safe, and often low-effective donor immunoglobulin, which currently is in medical practice. Preclinical trials are now at the final stage.
Virus strains have been developed for selective killing of cancer cells. Some works on creation of medicines based on them for clinical trials in the treatment of cancer are currently being done.



Research areas
Genome editing for the development of cell-based models of diseases and the search of efficient therapeutics
  • development of cell-based models of amyotrophic lateral sclerosis and hypertrophic cardiomyopathy for their use in pharmacological screening of candidate compounds
  • development of panels of human cells with inactivated DNA reparation pathways for the industrial genotoxicity testing without the use of animals





Development of new tools for molecular genetics and bioanalytical technologies
  • development of technologies of synthesis, immobilization and hybridization of phosphoryl guanidine oligonucleotides for molecular diagnostics
  • development of epigenomic and metabolomic signatures in defecation and blood for early diagnostics of colorectal cancer
  • development of technology of synthesis and purification of recombinant multi-target antibodies
  • producing strains of the enzymes necessary for in vitro genotoxicity analysis, and their forms with improved activity and specificity



Protection and repair systems as a basis of population genetic safety
Studies of functioning of human DNA reparation complexes, the establishment of the connection of DNA reparation with oncogenesis, neurodegeneration and ageing. DNA repair plays an important role in the maintenance of genetic information in cell, since different environmental agents as well as endogenic agents permanently cause DNA damage. Specific protein systems of DNA repair are able to fix any damages of DNA structure. Abnormalities in the work of DNA repair systems cause serious hereditary human diseases, malignancies and senescence. Investigations in this sphere are connected directly with the search of pathways of organisms' survival as well as with optimal ways of treatment of hereditary and oncological diseases.





Bioinformatics technologies of personalized diagnostics of social and economic essential diseases
  • Development and improvement of experimental and statistical methods of data analysis aimed at the search of new human disease biomarkers
  • Analysis of three-dimensional structure of genome and regulation of gene expression based on the data on long-range chromatin interactions.









Food safety in providing the quality of food products using modern biotechnology
Interdisciplinary studies in the field of food safety and quality will be directed to the evaluation of the possibility to use molecular genetic approaches for the control of technological properties of gramineous plants and to the development of new tools of analysis and modeling for identification of science-based prognostic scenarios for agrofood market. The use of modern genetic and genomic methods for revealing new genes, which determine the quality and nutrient value of the grain, and the ability of plants to give a heavy crop and to be used for the industrial production of natural food products.






Breakthrough projects
Boron Neutron Capture Therapy for oncology
Development of a new medical technology: accelerator-based epithermal neutron source for boron neutron capture therapy for oncological diseases Introduction of this medical technology into clinical practice in the Russian Federation

Publications in journals indexed in Scopus

News
More news

Scientific & Technical Council

Partners